4baseCare unveils India’s largest populationspecific tumour gene panel

4baseCare, a precision oncology startup in Bengaluru, has launched its product - TARGT Indiegene, India’s largest and first populationspecific tumour gene panel derived from Whole Exome and Whole Transcriptome data of over 1500 cancer patients across 28 different cancer types. Most of the cancer panels currently available in the market are based on data from the caucasian population, and the same panel is used for testing across all the geographies. For example, the TARGT Indiegene ‘ cancer panel is based on insights generated from tumour tissues of Indian cancer patients resulting in better success rates using precision medicine in the management of cancer. The insights from research have helped build the largest resource of mutational signatures identified in cancer patients in India. 4baseCare had already partnered with Wipro in July to build a framework of efficient, streamlined, and well-regulated workflows to develop advanced gene panels and to ensure the highest data quality, data security and regulatory compliance. Similarly, 4baseCare and ACTRECTata Memorial Centre join hands in the development of an AI-based clinical interpretation platform.